1998-2013年加利福尼亚州和纽约州感染性心内膜炎的趋势
该研究基于加州和纽约州强制州数据库,回顾性分析1998年1月1日至2013年12月31日期间75829例首次感染性心内膜炎住院患者。标准化年发病率保持稳定,但自体瓣膜心内膜炎比例下降,人工瓣膜和心脏装置相关心内膜炎比例上升,医疗相关非院内感染比例上升,调整后90天死亡风险逐年下降。
要点
- 标准化年发病率稳定在每10万人7.6至7.8例之间(年度百分比变化-0.06%,95%CI -0.3%至0.2%,P=0.59)。
- 心脏装置相关心内膜炎比例从1.3%升至4.1%(年度百分比变化8.8%,95%CI 7.8%至9.9%,P<0.001)。
- 调整后90天死亡风险逐年下降(调整风险比每年0.982,95%CI 0.978至0.986,P<0.001)。
核心结论
- 在加州和纽约州,1998年至2013年感染性心内膜炎的总体标准化发病率保持稳定,患者特征和病因随时间发生变化。
研究设计与样本
- 回顾性人群流行病学研究,纳入1998年1月1日至2013年12月31日期间加州和纽约州强制州数据库中首次感染性心内膜炎住院患者75829例(平均[SD]年龄62.3[18.9]岁;59.1%男性)。
主要发现
- 标准化年发病率在每10万人7.6例(95%CI 7.4至7.9)至7.8例(95%CI 7.6至8.0)之间(年度百分比变化-0.06%,95%CI -0.3%至0.2%,P=0.59)。
- 自体瓣膜心内膜炎比例从74.5%降至68.4%(年度百分比变化-0.7%,95%CI -0.9%至-0.5%,P<0.001)。
- 人工瓣膜心内膜炎比例从12.0%升至13.8%(年度百分比变化1.3%,95%CI 0.8%至1.7%,P<0.001),心脏装置相关心内膜炎比例从1.3%升至4.1%(年度百分比变化8.8%,95%CI 7.8%至9.9%,P<0.001)。
- 医疗相关院内感染性心内膜炎比例从17.7%降至15.3%(年度百分比变化-1.0%,95%CI -1.4%至-0.7%,P<0.001),医疗相关非院内感染性心内膜炎比例从32.1%升至35.9%(年度百分比变化0.8%,95%CI 0.5%至1.1%,P<0.001)。
- 口腔链球菌心内膜炎发病率未增加(未调整:年度百分比变化-0.1%,95%CI -0.8%至0.6%,P=0.77;调整后:年度百分比变化-1.3%,95%CI -1.8%至-0.7%,P<0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Prophylaxis and treatment guidelines for infective endocarditis have changed substantially over the past decade. In the United States, few population-based studies have explored the contemporary epidemiology and outcomes of endocarditis. OBJECTIVE: To quantify trends in the incidence and etiologies of infective endocarditis in the United States. DESIGN, SETTING, AND PARTICIPANTS: Retrospective population epidemiology study of patients hospitalized with a first episode of endocarditis identified from mandatory state databases in California and New York State between January 1, 1998, and December 31, 2013. EXPOSURE: Infective endocarditis. MAIN OUTCOMES AND MEASURES: Outcomes were crude and standardized incidence of endocarditis and trends in patient characteristics and disease etiology. Trends in acquisition mode, organism, and mortality were analyzed. RESULTS: Among 75 829 patients with first episodes of endocarditis (mean [SD] age, 62.3 [18.9] years; 59.1% male), the standardized annual incidence was stable between 7.6 (95% CI, 7.4 to 7.9) and 7.8 (95% CI, 7.6 to 8.0) cases per 100 000 persons (annual percentage change [APC], -0.06%; 95% CI, -0.3% to 0.2%; P = .59). From 1998 through 2013, the proportion of patients with native-valve endocarditis decreased (from 74.5% to 68.4%; APC, -0.7%; 95% CI, -0.9% to -0.5%; P < .001). Prosthetic-valve endocarditis increased (from 12.0% to 13.8%; APC, 1.3%; 95% CI, 0.8% to 1.7%; P < .001), and cardiac device-related endocarditis increased (from 1.3% to 4.1%; APC, 8.8%; 95% CI, 7.8% to 9.9%; P < .001). The proportion of patients with health care-associated nosocomial endocarditis decreased (from 17.7% to 15.3%; APC, -1.0%; 95% CI, -1.4% to -0.7%; P < .001). The proportion of patients with health care-associated nonnosocomial endocarditis increased (from 32.1% to 35.9%; APC, 0.8%; 95% CI, 0.5% to 1.1%; P < .001). The incidence of oral streptococcal endocarditis did not increase (unadjusted: APC, -0.1%; 95% CI, -0.8% to 0.6%; P = .77; adjusted: APC, -1.3%; 95% CI, -1.8% to -0.7%; P < .001). Crude 90-day mortality was unchanged (from 23.9% to 24.2%; APC, -0.3%; 95% CI, -1.0% to 0.4%; P = .44); adjusted risk of 90-day mortality decreased (adjusted hazard ratio per year, 0.982; 95% CI, 0.978 to 0.986; P < .001). CONCLUSIONS AND RELEVANCE: In California and New York State, the overall standardized incidence of infective endocarditis was stable from 1998 through 2013, with changes in patient characteristics and etiology over this time.
引用
- Toyoda N, Chikwe J, Itagaki S, et al. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017. PMID: 28444279. doi:10.1001/jama.2017.4287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。